Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

DDMAC, Soon To Be An Office, Hones In On DTC Advertising

Executive Summary

The planned elevation of FDA's Division of Drug Marketing, Advertising and Communications to office status comes amidst an intensified focus on direct-to-consumer advertising.

You may also be interested in...



FDA’s Guidance Document To-Do List

FDA’s Guidance Document To-Do List

FDA's Internet Promotion Guidance: One Down By Year-End; Four More To Go?

DDMAC is nearing completion of the first in what is expected to be a series of guidance documents pertaining to appropriate drug promotion on the Internet and with social media tools.

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS052746

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel